The Quantellect read.As of Nov 19, 2026, 10 active firms cover Enovis Corp: 10 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. Targets span $29.00 to $51.00, a moderate spread. The average target of $38.11 sits 41% above the current $27.11. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 9 to 10 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.87 next quarter toward $3.46 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 active firms
Buy
Strong Buy00%
Buy10100%
Neutral00%
Sell00%
Strong Sell00%
Based on 10 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$38.11
+40.6% upside
Average target across 9 active firms as of Nov 19, 2026 vs $27.11 current
Highest Target$51.00
Average Target$38.11
Lowest Target$29.00
Detailed analyst forecasts for ENOV
Showing 1–10 of 10 named analysts shown · 10 active firms in the rating projection
As of Nov 19, 2026, 10 of 10 active firms rate ENOV a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
ENOV EPS & revenue forecast
EPS · NEXT QUARTER
$0.87
Range $0.82 – $0.97 · 7 analysts · -2% YoY
Next period, 7 analysts expect Enovis Corp to earn $0.87 a share (range $0.82 – $0.97), versus $0.89 a year earlier. Full-year consensus is $3.70, growing to $3.46 the year after.
REVENUE · NEXT QUARTER
$612.9M
Range $606.9M – $620.1M · 7 analysts · +4% YoY
Revenue is expected to reach $612.9M (range $606.9M – $620.1M), +4.0% year-over-year. Full-year consensus is $2.3B, rising to $2.4B next year.
Top analysts covering Enovis Corp
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ENOV.
#1
Ryan Zimmerman
BTIG · Rank #212
Buy
$42.00+54.9% to target
Overall win rate
37%
+ Follow
#2
CC
Caitlin Cronin
Canaccord Genuity · Rank #260
Buy
$45.00+66.0% to target
Overall win rate
39%
+ Follow
#3
Mike Matson
Needham · Rank #285
Buy
$34.00+25.4% to target
Overall win rate
36%
+ Follow
#4
Vijay Kumar
Evercore ISI Group · Rank #331
Buy
$32.00+18.0% to target
Overall win rate
36%
+ Follow
#5
JW
Jason Wittes
Roth MKM · Rank #382
Buy
$75.00+176.7% to target
Overall win rate
40%
+ Follow
ENOV stock forecast FAQ
What is ENOV's average 12-month price target?+
The 9 active firms with a live target average $38.11 for Enovis Corp over the next 12 months, ranging from a $51.00 high to a $29.00 low, as of Nov 19, 2026.
Is ENOV stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 10 active firms as of Nov 19, 2026, 10 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for ENOV?+
The Street-high target is $51.00 (UBS), and the Street-low is $29.00 (BMO Capital). The average of all 9 active-firm targets is $38.11.
How many active Wall Street firms cover ENOV?+
10 active firms have a recognized rating on Enovis Corp as of Nov 19, 2026, and 9 active firms carry a live 12-month price target.
Who is the most accurate analyst covering ENOV?+
Among analysts who currently cover ENOV, Ryan Zimmerman of BTIG has the strongest overall Quantellect track record (Rank #212). Their current call is Buy with a $42.00 target.
What is Enovis Corp's projected EPS for next quarter?+
The consensus estimate is $0.87 per share (range $0.82 – $0.97) across 7 analysts. Full-year EPS is projected at $3.70, rising to $3.46 the following year.
How much revenue is Enovis Corp expected to report next quarter?+
Consensus revenue is $612.9M (range $606.9M – $620.1M). Full-year revenue is projected at $2.3B, growing to $2.4B next year.
Have analysts been upgrading or downgrading ENOV lately?+
As of Nov 19, 2026, 10 of 10 active firms rate ENOV a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ENOV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.